OGF, a chemically termed [Met5]-enkephalin, is an endogenous pentapeptide with potential antineoplastic and antiangiogenic activities that binds to and activates the OGFr, present on some tumor cells and vascular cells, thereby inhibiting tumor cell proliferation and angiogenesis [29, 30•, 31]. Here, OGFR is linked to neoplasm.